Eleven Biotherapeutics Inc. (EBIO) Shares Up 4.8%
Shares of Eleven Biotherapeutics Inc. (NASDAQ:EBIO) shot up 4.8% during trading on Monday . The stock traded as high as $2.46 and last traded at $2.42, with a volume of 734,275 shares trading hands. The stock had previously closed at $2.31.
The company’s 50 day moving average is $2.11 and its 200-day moving average is $1.10. The firm’s market capitalization is $37.87 million.
In related news, major shareholder Boxer Capital, Llc sold 1,042,000 shares of the firm’s stock in a transaction dated Monday, June 13th. The stock was sold at an average price of $2.74, for a total transaction of $2,855,080.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Eleven Biotherapeutics, Inc is a clinical-stage biopharmaceutical company. The Company through AMP-Rx, a protein engineering platform, is engaged in the discovery and development of protein therapeutics to treat diseases of the eye. The Company designs, engineers and generates a pipeline of protein therapeutic candidates that target cytokines, which are central to diseases of the eye.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.